Project Details
Key findings
A novel TRPA1 antagonist dependently reversed allodynia in STZ neuropathic pain model.
PK PD was established.
This provides novel data to broaden our understanding on blocking this mechanism (TRPA1) in our diabetes neuropathic pain model and Identifies the potential of targeting TRPA1 receptors in diabetic neuropathic pain.
PK PD was established.
This provides novel data to broaden our understanding on blocking this mechanism (TRPA1) in our diabetes neuropathic pain model and Identifies the potential of targeting TRPA1 receptors in diabetic neuropathic pain.
| Status | Finished |
|---|---|
| Effective start/end date | 20/08/14 → 10/10/14 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.